Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950129-07-000698
Filing Date
2007-02-14
Accepted
2007-02-14 14:26:05
Documents
2
Group Members
AMVESCAP PLCPOWERSHARES CAPITAL MANAGEMENT L L C

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G h43493lsc13g.txt SC 13G 9054
2 JOINT FILING AGREEMENT h43493lexv99wa.txt EX-99.A 9619
  Complete submission text file 0000950129-07-000698.txt   21040
Mailing Address 30 FINSBURY SQUARE LONDON EC2A 1AG ENGLAND X0 EC2A 1AG
Business Address 30 FINSBURY SQUARE LONDON EC2A 1AG ENGLAND X0 EC2A 1AG 442076380731
AMVESCAP PLC/LONDON/ (Filed by) CIK: 0000914208 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 50 AUDUBON ROAD SUITE B WAKEFIELD MA 01880
Business Address 50 AUDUBON ROAD SUITE B WAKEFIELD MA 01880 781-224-1444
NUCRYST Pharmaceuticals Corp. (Subject) CIK: 0001344674 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-81536 | Film No.: 07618310
SIC: 3841 Surgical & Medical Instruments & Apparatus